45 evolution "https:" "https:" "https:" "https:" "https:" "https:" "U.S" uni jobs at University of Lund
Sort by
Refine Your Search
-
Description of the workplace The Department of Immunotechnology conducts research ranging from advanced technology development to biomedical studies. The main research areas include immuno-oncology
-
documentation. This is a broad and responsible role encompassing chemical governance, user training, risk assessment, and safety development across the cleanroom facility. The successful candidate will support
-
, from the early development of telecommunications to the space race. Today, driven by the need to engineer ever larger systems, Automatic Control is more relevant than ever. The department of Automatic
-
setting, supporting innovative science and engineering teams and contributing to the development of cutting-edge scientific infrastructure. You will play a key role in shaping safety practices from early
-
with other safety experts and functions at MAX IV Provide guidance to engineering and research teams on integrating laser safety by design during early development phases Be able to validate safety
-
, econometrics, applied microeconomics, and macroeconomics. For more information, please visit: https://www.lusem.lu.se/organisation/department-economics/research Job Assignments The holders of these positions
-
projects. More information about the doctoral programme is available on the department’s website: (https://www.iko.lu.se/en/research/doctoral-studies). Eligibility General eligibility for third-cycle
-
background and interest in soil microbial ecology, ecosystem ecology and biogeochemistry. You will be part of the Microbial Biogeochemistry in Lund (MBLU) research environment (https://portal.research.lu.se/en
-
, and genome‑modifying technologies. The research group works on several projects related to the development and use of new in vitro model systems for neurodegenerative diseases and brain cancer
-
of Medicine is currently conducting research on the mechanisms underpinning the epigenetic control of the repetitive genome in stem cell models of early human development. The group was established in 2022 by